Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN Study.

Introduction: Injectable extended-release formulations of luteinizing hormone-releasing hormone agonists (LHRHa) have simplified the treatment of prostate cancer with a satisfactory level of androgen castration. This study aims to determine the percentage of patients whose initial LHRHa prescription was renewed during follow-up, how many changed formulation and how their quality of life evolved.

Methods: This is an observational, prospective, multicentre study of men with prostate cancer who were to receive treatment with LHRHa (triptorelin every 3 or 6 months, leuprorelin every 3 or 6 months, or goserelin every 3 months) for 24 months.

A Multicenter Study of 2-year Outcomes Following Hyperthermia Therapy with Mitomycin C in Treating Non-Muscle Invasive Bladder Cancer: HIVEC-E.

Introduction: High grade, non-muscle invasive bladder cancer (NMIBC) is usually treated with intravesical Bacillus Calmette-Guérin. Chemohyperthermia therapy (CHT) may be a novel alternative therapy for the treatment of NMIBC.

Objective: To evaluate the recurrence-free survival (RFS) of patients treated with CHT using the Combat bladder recirculation system (BRS) for NMIBC.

Priapism Produced by Penile Metastasis from Colon Cancer.

Introduction And Objective: The penile metastasis is a rare clinical entity. The objective is to present the first documented case report of penile metastasis from right colon.

Clinical Case: A case of a 78-year-old man who was diagnosed with penile metastasis from right colon.

[Relevance of clinical and serum parameters on severe urinary sepsis after renal obstruction.].

Introduction: Urosepsis is an underdiagnosed entity with high morbidity and mortality and significant associated costs. The delay in diagnosis leads to an increased risk of multiorgan failure and death. Although its prognosis is better than that of other sepsis, the mortality rate is 20 - 40%.

[Prognostic factors in renal cancer with venous thrombus survival analysis.].

Objectives: To analyze surgery for renal cancer with venous thrombus at different levels, perioperative complications and prognostic factors associated to overall, cancer-specific and disease-free survival.

Material And Methods: Retrospective analysis of 42 cases of renal cancer with venous thrombus performed between 2005 and 2015. The level reached by the thrombus was established according to the Mayo Clinic classification.

[Small cell carcinoma of the bladder: Our experience].

Objectives: Small cell carcinoma of the bladder shows low incidence and poor survival; thus, treatment algorithms based on randomized studies are unavailable. The aim of the present study is to review our case series.

Methods: Observational retrospective study of 10 patients diagnosed with small cell carcinoma of the bladder between 2006 and 2013.

[Tumors of the upper urinary tract. Our experience].

Objectives: To study the clinical presentation, diagnosis, treatment, and evolution of upper urinary tract tumours.

Methods: We carried out a retrospective study on the upper urinary tract tumours treated in our centre, HCU Valladolid, between 1994 and 2007.

Results: 65 tumours were diagnosed, although only 59 were valid for the study.

[Pelvic recurrence after radical cystectomy for bladder cancer].

Objectives: We report the case of a male patient who had undergone radical cystectomy and orthotopic neobladder for bladder cancer presenting with local recurrence eight months later.

Methods: Diagnostic tests included CT scan and ultrasound guided transrectal biopsy

Results: With the diagnosis of local recurrence he underwent chemotherapy and radiotherapy

Conclusions: The pelvic recurrence of transitional cell carcinoma after radical cystectomy is rare and prognosis is poor. It is frequently associated with advanced tumor stage.